How to Test for Endometriosis: Your Complete Guide to Diagnosis

Why Endometriosis Is So Hard to Diagnose

Endometriosis is difficult to diagnose because its symptoms overlap with dozens of other conditions and its lesions are invisible to routine blood panels. The 7-to-10-year diagnostic delay documented across multiple national studies is not a medical mystery. It is a predictable consequence of invisible tissue growing outside the uterus with no reliable external marker.

The Biology Behind the Delay

Endometrial-like tissue implants on the ovaries, peritoneum, bladder, bowel, and occasionally distant sites. Each menstrual cycle drives these implants to bleed, scar, and inflame surrounding tissue. Because the abdomen has no way to drain this internal bleeding, dense adhesions form over years.

Symptoms intensify gradually, so patients and clinicians often attribute the pain to normal menstruation. A 2011 survey published in the journal Human Reproduction found that 58% of women visited a physician three or more times before receiving a referral to a specialist [1].

Conditions That Mimic Endometriosis

Pain cannot be used alone to confirm the diagnosis because irritable bowel syndrome, interstitial cystitis, pelvic inflammatory disease, adenomyosis, and ovarian cysts produce nearly identical symptom profiles. Adenomyosis in particular coexists with endometriosis in up to 35% of cases [2].

A thorough differential diagnosis must precede any imaging or surgical workup. Gynecologists typically rule out infectious causes with a cervical swab, exclude pelvic inflammatory disease, and obtain a pregnancy test before proceeding.

Step 1: Symptom History and Pain Mapping

The diagnostic process starts with a detailed symptom history, not a blood draw. Clinicians use structured questionnaires to assess pain timing, severity, and relationship to the menstrual cycle.

The Classic Symptom Triad

Three symptoms together raise clinical suspicion enough to justify imaging:

1. Dysmenorrhea (painful periods) that is severe enough to limit daily activity or require prescription-strength analgesia.
2. Dyspareunia (pain during or after intercourse), particularly deep penetration pain that worsens around menstruation.
3. Chronic pelvic pain lasting 6 months or longer, unrelated to cycle phase.

Additional red flags include cyclical bowel symptoms (dyschezia, rectal bleeding during menstruation), cyclical urinary urgency or hematuria, and infertility of unexplained origin. The American College of Obstetricians and Gynecologists (ACOG) 2018 practice bulletin states that "endometriosis should be suspected in women of reproductive age with pelvic pain, dysmenorrhea, dyspareunia, or infertility" [3].

Pain Diaries as a Diagnostic Tool

Patients who track pain scores on a 0-to-10 numeric scale across two to three full menstrual cycles provide clinicians with data that is far more actionable than a single-visit recall. Free apps such as Clue and Phendo were validated against paper diaries in a 2019 study published in npj Digital Medicine and showed high concordance for cycle-related symptom capture [4].

A HealthRX-developed intake framework used by our clinical team asks patients to rate pain on five dimensions: period pain, mid-cycle pain, intercourse pain, bowel-related pain, and bladder-related pain, each scored separately across the same cycle. This multi-axis mapping allows the reviewing clinician to identify anatomical patterns before any imaging is ordered.

Step 2: Pelvic Examination

A physical pelvic exam cannot confirm endometriosis, but specific findings raise suspicion significantly. The clinician is looking for nodularity, tenderness, and restricted uterine mobility.

What the Clinician Is Feeling For

During a bimanual exam, fixed retroverted uterus (uterus tipped backward and adhered to surrounding tissue) is a frequent finding in moderate-to-severe disease. Nodularity along the uterosacral ligaments, felt on rectovaginal examination, corresponds to deep infiltrating endometriosis (DIE) in up to 70% of cases confirmed by laparoscopy [5].

A speculum exam may reveal visible blue or purple lesions on the vaginal fornix or cervix in cases of vaginal endometriosis, though this presentation is uncommon.

Limitations of Physical Examination

Sensitivity for detecting endometriosis by pelvic exam alone is estimated at 25% to 45% depending on disease stage and examiner experience [5]. Superficial peritoneal lesions, which represent Stage I and II disease, are rarely palpable. Examination under anesthesia (EUA) improves detection but is rarely performed as a standalone procedure.

Step 3: Imaging Studies

Imaging is the principal non-invasive diagnostic tool, but the type of imaging ordered matters enormously. A standard transabdominal ultrasound is inadequate for most endometriosis patterns.

Transvaginal Ultrasound (TVS)

Transvaginal ultrasound performed by a sonographer experienced in endometriosis is the first-line imaging modality recommended by the European Society of Human Reproduction and Embryology (ESHRE) 2022 guidelines [6]. It detects endometriomas (ovarian cysts filled with old blood, classically described as homogeneous low-level echoes) with sensitivity of 73% to 94% and specificity of 94% to 99% [6].

TVS is substantially less reliable for peritoneal implants and bowel endometriosis. For those patterns, additional imaging is needed.

MRI of the Pelvis

Pelvic MRI with a dedicated endometriosis protocol (T1-weighted with fat saturation, T2-weighted, and diffusion-weighted sequences) is the preferred modality for mapping deep infiltrating disease. A 2017 meta-analysis in Radiology (pooling 37 studies, N=2,609) reported MRI sensitivity of 94% and specificity of 77% for overall endometriosis, and sensitivity of 88% for bowel involvement [7].

MRI is particularly valuable before surgical planning because it identifies ureteral, bladder, and rectovaginal septum involvement that changes the surgical approach and the specialist team required.

Bowel Ultrasound (Rectal Water Contrast Sonography)

Rectal water contrast sonography (RWC-TVS) is a specialized technique in which the rectum is filled with water to improve visualization of the rectosigmoid junction. In experienced centers, it matches MRI for detecting bowel involvement and costs significantly less. A 2020 study in Ultrasound in Obstetrics and Gynecology reported sensitivity of 91% and specificity of 98% for rectal endometriosis using RWC-TVS [8].

Step 4: Blood Tests and Biomarkers

No blood test can confirm or rule out endometriosis with the accuracy needed for clinical decision-making. Several markers are used adjunctively.

CA-125

CA-125 is a glycoprotein elevated in conditions that irritate or damage the peritoneum. In endometriosis, serum CA-125 >35 IU/mL has sensitivity of approximately 50% for Stage I-II disease and 60% to 80% for Stage III-IV [9]. Elevated CA-125 is also seen in uterine fibroids, ovarian cancer, peritonitis, and even early pregnancy, making it a poor standalone test.

ACOG explicitly states that CA-125 is not recommended as a primary screening test for endometriosis [3].

Emerging Biomarkers Under Investigation

Several research programs are pursuing blood or urine biomarkers that could replace or defer laparoscopy:

• miRNA panels. A 2021 study in Fertility and Sterility identified a 5-microRNA serum signature with area under the curve (AUC) of 0.87 in a discovery cohort (N=200), though independent validation is pending [10].
• Endometrial receptivity testing. The ERA (Endometrial Receptivity Analysis) test assesses gene expression in endometrial biopsies obtained in-office, but its primary use is implantation timing for IVF rather than endometriosis diagnosis.
• Neutrophil-to-lymphocyte ratio (NLR). An NLR above 2.5 has been proposed as a cheap inflammatory proxy, but the predictive value is low (AUC ~0.65) and it is not guideline-endorsed [11].

No biomarker panel has received FDA clearance for endometriosis diagnosis as of January 2025.

Step 5: Diagnostic Laparoscopy with Histology

Laparoscopy remains the definitive diagnostic procedure. It is a minimally invasive surgery performed under general anesthesia in which a camera is inserted through small abdominal incisions to directly visualize pelvic organs.

What the Surgeon Is Looking For

Classic lesions appear as powder-burn or gunshot lesions: small black or brown spots on the peritoneum from hemosiderin deposits. Atypical lesions may be clear vesicles, red flame-shaped areas, or white scars and are frequently missed by surgeons without subspecialty training. A 2017 study in the Journal of Minimally Invasive Gynecology found that atypical lesions were present in 40% of patients whose standard-appearance lesions were biopsied and confirmed [12].

Biopsy with histological confirmation showing endometrial glands and stroma outside the uterus is required to meet the pathological standard of diagnosis. Visual diagnosis alone without biopsy carries a false-positive rate of up to 50% for atypical lesions.

ASRM Staging at Laparoscopy

The American Society for Reproductive Medicine (ASRM) revised staging system (rASRM) assigns points based on lesion size, location, depth, and the presence and severity of adhesions:

• Stage I (Minimal): 1 to 5 points. Superficial peritoneal implants.
• Stage II (Mild): 6 to 15 points. Deeper implants, small endometriomas.
• Stage III (Moderate): 16 to 40 points. Multiple deep implants, endometriomas, adhesions.
• Stage IV (Severe): Greater than 40 points. Extensive disease, large endometriomas, dense adhesions.

Stage does not reliably predict pain severity. Some women with Stage I disease report debilitating pain; others with Stage IV disease report only mild discomfort [13].

Operative vs. Diagnostic Laparoscopy

Most gynecologic surgeons treat lesions at the same procedure rather than performing a purely diagnostic laparoscopy. This combined approach avoids a second anesthetic exposure. ESHRE 2022 recommends that when laparoscopy is performed for suspected endometriosis, "surgeons should be prepared to treat all visible lesions at the same time" [6].

Staging, Classification, and What the Results Mean

Beyond rASRM staging, two additional classification systems are used in clinical practice and research.

The Enzian Classification

The Enzian system scores deep infiltrating endometriosis specifically, using compartment-based notation (A for rectovaginal, B for parametrial, C for sigmoid, and additional codes for bladder and ureteral involvement). It was updated in 2021 and is increasingly used in academic endometriosis centers to standardize surgical reporting [14].

#Endometriosis Phenotyping for Treatment Planning

Treatment decisions depend less on stage and more on the specific phenotype:

• Superficial peritoneal endometriosis responds to hormonal suppression.
• Ovarian endometriomas require surgical cystectomy for definitive treatment, though recurrence rates at 2 years are approximately 20%.
• Deep infiltrating endometriosis involving bowel or bladder may require multidisciplinary surgery with colorectal and urology teams.

Understanding phenotype from imaging before surgery allows appropriate surgical team assembly and reduces the risk of incomplete resection.

Hormonal Trials as a De Facto Diagnostic Test

In patients with classic symptoms and no findings on imaging, some clinicians prescribe a 3-month empirical trial of hormonal therapy (combined oral contraceptive pill or a progestin such as norethindrone acetate 5 mg daily) before proceeding to laparoscopy. Pain reduction during the trial supports but does not confirm endometriosis, because hormonal agents relieve dysmenorrhea from multiple causes.

ESHRE 2022 states that "empirical treatment with hormonal drugs may be offered to women with suspected endometriosis as an alternative to surgical diagnosis in the absence of contraindications," provided the clinician has adequately excluded other pathology [6]. This approach avoids surgical risk but delays definitive staging and does not establish a tissue diagnosis.

Navigating Diagnosis as a Patient: Practical Steps

Getting to a diagnosis requires persistence and systematic advocacy.

Build Your Case Before the Appointment

Arrive with at least two to three months of pain diary data, a list of all analgesics tried and their effectiveness (including NSAIDs such as ibuprofen 600 mg three times daily and naproxen 500 mg twice daily), and any family history of endometriosis. First-degree relatives of affected women carry a 7-fold increased risk [15].

Request Specialist Referral Early

General practitioners and even general gynecologists may not perform the rectovaginal exam or order the right ultrasound protocol. An endometriosis specialist, or at minimum an advanced laparoscopic surgeon, should be involved when symptoms persist beyond 6 months without explanation.

Questions to Ask Your Clinician

• "Are you ordering a transvaginal ultrasound or transabdominal? I would like transvaginal."
• "Does this imaging center use a dedicated endometriosis ultrasound protocol?"
• "If laparoscopy is recommended, will you excise or ablate lesions, and what is your personal recurrence data?"

Excision (cutting out lesions) has lower recurrence rates than ablation (burning the surface) for deep disease, based on a 2021 Cochrane review that found symptom recurrence was 15% lower at 12 months with excision [16].